Proteina to Raise 7.3 Billion Won in Private Placement of Convertible Preferred Shares
Bitget2026/11/04 09:05- Proteina announced a KRW 7.3 billion private placement of 151,886 registered convertible preferred shares on November 4, 2026.
- The issue price of KRW 48,061 per share represents a 2.23% premium to the reference price.
- Proceeds will allocate KRW 5.2 billion to AI Biofoundry facilities, with KRW 2.1 billion funding platform research and drug-candidate development.
- Payment is due November 12, 2026; all shares carry a one-year lockup.
- The preferred shares initially convert one-for-one into common shares, with conversion requests permitted from November 13, 2027, through October 13, 2031.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.

Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Europe Becomes a Safe Haven Amid AI Turbulence! Citi Turns Bullish on European Stocks, Downgrades US Stocks: Low AI Exposure Seen as Key Advantage
Citigroup strategists have downgraded the rating of U.S. stocks and upgraded the rating of European stocks, following the recent market turbulence caused by upheaval in the artificial intelligence industry.
